[Absorption, distribution and excretion of  14 C-labelled 6,6,9-trimethyl-9-azabicyclo(3,3,1)non-3 -yl a,a-di(2-thienyl)glycolate hydrochloride monohydrate (PG-501)].
D000284:Administration, Oral; D000818:Animals; D000978:Antiparkinson Agents / Q000378:metabolism*; D001345:Autoradiography; D005260:Female; D006571:Heterocyclic Compounds / Q000378:metabolism*; D007275:Injections, Intravenous; D008297:Male; D051379:Mice; D011247:Pregnancy
D000978:Antiparkinson Agents; D006571:Heterocyclic Compounds